- Home
- GENB vs ADUS Comparison
GENB vs ADUS Comparison
Compare GENB & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GENB | ADUS |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2026 | 2009 |
Fundamental Metrics
Financial Performance| Metric | GENB | ADUS |
|---|---|---|
| Price | $15.91 | $113.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $23.20 | ★ $133.78 |
| AVG Volume (30 Days) | ★ 1.4M | 153.6K |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.40 |
| EPS | N/A | ★ 2.85 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.17 |
| Revenue Next Year | $16.58 | $4.70 |
| P/E Ratio | ★ N/A | $40.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.00 | $87.95 |
| 52 Week High | $22.67 | $124.44 |
Technical Indicators
Market Signals| Indicator | GENB | ADUS |
|---|---|---|
| Relative Strength Index (RSI) | 50.75 | N/A |
| Support Level | $11.82 | N/A |
| Resistance Level | $16.75 | N/A |
| Average True Range (ATR) | 0.87 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 41.84 | 0.00 |
Price Performance
Historical ComparisonAbout GENB Generate Biomedicines Inc. Common Stock
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.